Institut Paoli-calmettes
Clinical trials sponsored by Institut Paoli-calmettes, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may predict kidney cancer drug response Results expected Dec 2026 (estimated)
- New antibody drug takes on advanced tumors in first human trial Results expected Mar 2027 (estimated)
-
Kidney removal after immunotherapy may offer cure for select patients
Cure Recruiting nowThis study tests whether removing the kidney after successful immunotherapy can help patients with metastatic kidney cancer stop all treatment and stay cancer-free. About 60 adults whose tumors have shrunk significantly with immunotherapy will either have surgery and stop therapy…
Sponsor: Institut Paoli-Calmettes • Aim: Cure
Last updated Jun 27, 2026 11:03 UTC
-
Could some AML patients ditch chemo pills after a year?
Disease control Recruiting nowThis study looks at whether people with acute myeloid leukemia (AML) who have responded well to a year of treatment with venetoclax and azacitidine can safely stop taking these drugs. Researchers will monitor 50 patients closely for signs of relapse and compare them to a similar …
Phase 2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for tough leukemia: dasatinib tested after standard therapy fails
Disease control Recruiting nowThis phase 2 trial is testing the drug dasatinib alone in adults with acute myeloid leukemia (AML) whose cancer did not respond to the usual combination of venetoclax and azacitidine. The main goal is to see if dasatinib can shrink the leukemia after two months of treatment. Abou…
Phase 2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Scientists hunt for weaknesses in pancreatic Cancer's fuel system
Knowledge-focused Recruiting nowThis study is analyzing tissue and blood samples from 64 people with pancreatic cancer that has spread. Researchers want to understand how cancer cells change their energy use and interact with surrounding cells. The goal is to find new targets for treatment and better ways to pr…
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can a blood test tell who will respond to lung cancer immunotherapy?
Knowledge-focused Recruiting nowThis study is collecting blood and tumor samples from 200 people with non-small cell lung cancer to find biological markers that predict whether immunotherapy will work. Researchers will compare samples taken before treatment and at the time the disease gets worse. The goal is to…
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC